Professor Paolo Pozzilli MD is Full Professor of Endocrinology & Metabolism at University Campus Bio-Medico in Rome, Italy, and Professor of Diabetes and Clinical Research at the Centre of Immunobiology, Blizard Institute, St.Bartholomew’s and the London School of Medicine, Queen Mary, University of London, UK. He trained in Medicine and specialized in Endocrinology & Metabolic Diseases from Sapienza University of Rome, Italy.
He works mainly in the field of diabetes with particular focus to type 1 diabetes (T1D) pathogenesis and prevention, and in collaboration with several investigators worldwide. He has published over 500 scientific articles (Pubmed), books and reviews on different aspects of diabetes, from basic studies on the autoimmune mechanisms of T1D to clinical trials testing novel therapies for T1D and T2D. He set up with others the EURODIAB study on the incidence of childhood T1D, that is the most comprehensive mapping of the incidence of T1D in Europe. He has been the regional P.I. for TRIGR, the longest trial for the primary prevention of T1D. He established a joint International PhD programme in Integrated Biomedical Sciences ad Boethics including 4 Universities (Campus Bio-Medico University of Rome; Barts & the London, Queen Mary, UK; University of Ulm, Germany; University of Barcelona, Spain. Among the several clinical trials he carried out, the most relevant international ones where he acted as Leader or regional P.I. include ENDIT, TRIGR, Action LADA, and more recently EMPAREG, EXSCEL, CANVAS, IN-TANDEM3, AWARD-8 and BANTING trials. His collaborations with investigators in Europe, US, China and the Middle East led to the implementation of joint research programmes for the identification of T1D pathogenic mechanisms leading to beta cell destruction. In the early 2000s and for 10 years he has been a member of the scientific review committee of the Juvenile Diabetes Research Foundation (USA). He has also served for the EU in the grant selection for the 5th Framework Programme and represented the European Association for the Study of Diabetes at the European Medical Agency (EMA) where he has often consulted for other trials.
Professor Pozzilli has received several Awards , the most significant ones include the Andrew Cudworth Memorial Award by the British Diabetic Association,(1984), the Morgagni Award for Best Young Investigator by the International Society of Metabolism (1989), the Award by the Italian Society of Diabetes (1994), the Marie Kugel Award by the Juvenile Diabetes Foundation (USA (2003 and 2007), the Diabetes Honoris Causa Award by the Paulescu Foundation, Romanian Diabetes Society (2013), the Celso Prize by the Italian Society of Diabetes (2014) and the Menarini Award, Joseph Hoet Memorial Lecture by the World Foundation on Diabetes Prevention (2016). He published 520 papers (Pubmed).
He is currently Editor in Chief of Diabetes Metabolism Research & Reviews (Wiley Publ.), Founding Chairman of the Department of Endocrinology & Diabetes and of the MD International programme in Medicine at Campus Bio-Medico University of Rome.
